Literature DB >> 23180318

Pathogenesis of hepatic encephalopathy: lessons from nitrogen challenges in man.

Hanan Mardini1, Christopher Record.   

Abstract

Induction of hyperammonaemia with nitrogen challenge in man can be used to study the pathogenesis and treatment of hepatic encephalopathy complicating cirrhosis. Initially 20 g of glutamine was given orally as a flavored solution which resulted in doubling of blood ammonia concentration and this was associated with a deterioration in performance of the choice reaction time. The effect could have been due to a direct effect of glutamine rather than the ammonia generated so in subsequent experiments a glutamine free mixture of amino acids resembling the composition of haemoglobin was used (gastrointestinal bleeding is a known precipitant of hepatic encephalopathy). In Child grade B and C patients, 2-3 h after 54 g, slowing of the EEG was observed. The cerebral effects of induced hyperammonaemia were studied with diffusion weighted imaging and MR spectroscopy after giving 54 g of a mixture of threonine, serine and glycine when apparent diffusion coefficient increased. Also the change in ammonia levels correlated with the change in cerebral glutamine levels (r = 0.78, p = 0.002) suggesting intra cerebral formation of glutamine from ammonia and this may have accounted for the fall in cerebral myoinositol concentrations observed. Finally a colonic source for ammonia was confirmed by administering urea using colon coated capsules when ammonia concentrations slowly increased from 5 h after administration and rapidly after 10 h. In two patients the hyperammonaemia was ameliorated by pre treatment with Rifaximin 1200 mg per day for 1 week. Nitrogen challenge studies are thus a valuable model for studying new treatments for hepatic encephalopathy without the need to simultaneously treat precipitating factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180318     DOI: 10.1007/s11011-012-9362-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  43 in total

1.  Decreased plasma and tissue isoleucine levels after simulated gastrointestinal bleeding by blood gavages in chronic portacaval shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Ammonia metabolism in normal and portacaval-shunted rats.

Authors:  A J Cooper
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 3.  Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.

Authors:  A S Basile; E A Jones
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

4.  Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis.

Authors:  Sherzad Balata; Steven W M Olde Damink; Karen Ferguson; Ian Marshall; Peter C Hayes; Nicolaas E p Deutz; Roger Williams; Joanna Wardlaw; Rajiv Jalan
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.

Authors:  Hanan Mardini; Fiona E Smith; Christopher O Record; Andrew M Blamire
Journal:  J Hepatol       Date:  2011-02-03       Impact factor: 25.083

Review 6.  Glutamine: a Trojan horse in ammonia neurotoxicity.

Authors:  Jan Albrecht; Michael D Norenberg
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

7.  Brain indoles in human hepatic encephalopathy.

Authors:  H al Mardini; E J Harrison; P G Ince; K Bartlett; C O Record
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

8.  Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.

Authors:  V L Rao; R M Audet; R F Butterworth
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

9.  Correlation between ammonia levels and the severity of hepatic encephalopathy.

Authors:  Janus P Ong; Anjana Aggarwal; Derk Krieger; Kirk A Easley; Matthew T Karafa; Frederick Van Lente; Alejandro C Arroliga; Kevin D Mullen
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

10.  Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat.

Authors:  K N Oppong; K Bartlett; C O Record; H al Mardini
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

View more
  6 in total

Review 1.  Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.

Authors:  Ileana Pacheco-Colón; Stanley Fricke; John VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

2.  Low hemoglobin levels are associated with upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Biomed Rep       Date:  2016-07-27

3.  Patient characteristics with high or low blood urea nitrogen in upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 4.  Multimodality magnetic resonance imaging in hepatic encephalopathy: an update.

Authors:  Xiao-Dong Zhang; Long-Jiang Zhang; Sheng-Yong Wu; Guang-Ming Lu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 5.  Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy.

Authors:  Nina Kimer; Aleksander Krag; Lise L Gluud
Journal:  Patient Prefer Adherence       Date:  2014-03-18       Impact factor: 2.711

6.  Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy.

Authors:  Yuqing Zhou; Qian Dong; Rong Zhang; Shunfeng Zhou; Linqiang Li; Keran Cheng; Rui Kong; Qiang Yu; Shizan Xu; Jingjing Li; Sainan Li; Jiao Feng; Liwei Wu; Tong Liu; Xiya Lu; Kan Chen; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Gastroenterol Res Pract       Date:  2016-12-21       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.